[Results of the 2024 Amendment to the Infectious Disease Control and Prevention Act].

OBJECTIVES

This report analyzed the key amendments to the Infectious Disease Control and Prevention Act of 2024, comprehensively examined their implications and anticipated effects on public health policy, and proposed future directions for legal revisions.

METHODS

Focusing on official amendment notices from the Korea Disease Control and Prevention Agency, revised legal provisions were thoroughly summarized, and policy implications were identified.

RESULTS

Recent amendments aimed to enhance the effectiveness of the infectious disease response system by expanding the authority of local governments, broadening the recipients of vaccination pre-notifications, strengthening personal data protection, establishing a legal basis for a National Advanced Vaccine Development Center, and easing reporting requirements for the disinfection industry.

CONCLUSIONS

The 2024 amendment to the Infectious Disease Control and Prevention Act is evaluated as having laid a more structured and effective foundation for responding to public health emergencies. These revisions are significant for enhancing regionally tailored governance, strengthening prevention-centered health management, improving personal data protection, and supporting the public health industry, including advanced vaccine development.